Condition
Recurrent Ventricular Tachycardia
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Completed2
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06281977Phase 3Recruiting
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
NCT06931821Not ApplicableNot Yet Recruiting
Functional ElectroAnatomiC Isochronal Late Activation Mapping for Empiric VT Ablation Trial
NCT02799693CompletedPrimary
Intramural Needle Ablation for Ventricular Tachycardia
NCT00905853Phase 4CompletedPrimary
Ventricular Tachycardia (VT) Ablation or Escalated Drug Therapy
Showing all 4 trials